Fund profile
Tickers
BIB
Fund manager
Total assets
$95.35 mm
Liabilities
$1.06 mm
Net assets
$94.29 mm
Number of holdings
232.00
BIB stock data
Top 200 of 232 Holdings
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
U.S. Treasury Bills | 9.87 mm | 10.00 mm principal | 10.47 | Short-term investment vehicle | Long | USA |
GILD Gilead Sciences, Inc. | 5.48 mm | 69.33 k shares | 5.81 | Common equity | Long | USA |
REGN Regeneron Pharmaceuticals, Inc. | 5.39 mm | 4.55 k shares | 5.71 | Common equity | Long | USA |
AMGN Amgen Inc. | 4.86 mm | 14.57 k shares | 5.16 | Common equity | Long | USA |
VRTX Vertex Pharmaceuticals Incorporated | 4.85 mm | 9.79 k shares | 5.15 | Common equity | Long | USA |
Total Return Swap
UBS AG
|
4.85 mm | 11.34 k contracts | 5.14 | Equity derivative | N/A | USA |
Repurchase Agreement | 4.17 mm | 4.17 mm principal | 4.42 | Repurchase agreement | Long | USA |
Repurchase Agreement | 3.21 mm | 3.21 mm principal | 3.41 | Repurchase agreement | Long | USA |
Total Return Swap
BNP Paribas SA
|
3.11 mm | 4.08 k contracts | 3.30 | Equity derivative | N/A | USA |
AstraZeneca plc
|
2.50 mm | 28.55 k shares | 2.65 | Common equity | Long | UK |
ALNY Alnylam Pharmaceuticals, Inc. | 1.99 mm | 7.59 k shares | 2.12 | Common equity | Long | USA |
BIIB Biogen Inc. | 1.79 mm | 8.74 k shares | 1.90 | Common equity | Long | USA |
MRNA Moderna, Inc. | 1.76 mm | 22.68 k shares | 1.86 | Common equity | Long | USA |
U.S. Treasury Bills | 1.74 mm | 1.75 mm principal | 1.84 | Short-term investment vehicle | Long | USA |
Repurchase Agreement | 1.60 mm | 1.60 mm principal | 1.70 | Repurchase agreement | Long | USA |
Repurchase Agreement | 1.28 mm | 1.28 mm principal | 1.36 | Repurchase agreement | Long | USA |
ILMN Illumina, Inc. | 1.26 mm | 9.56 k shares | 1.33 | Common equity | Long | USA |
BMRN BioMarin Pharmaceutical Inc. | 1.04 mm | 11.40 k shares | 1.10 | Common equity | Long | USA |
ARGX argenx SE | 994.81 k | 1.92 k shares | 1.06 | Common equity | Long | Netherlands |
UTHR United Therapeutics Corporation | 968.13 k | 2.66 k shares | 1.03 | Common equity | Long | USA |
SNY Sanofi | 951.36 k | 16.91 k shares | 1.01 | Common equity | Long | France |
INCY Incyte Corporation | 885.82 k | 13.49 k shares | 0.94 | Common equity | Long | USA |
INVESCO GOVERNMENT & AGENCY PORTFOLIO OPEN-END FUND USD | 880.26 k | 880.26 k shares | 0.93 | Short-term investment vehicle | Long | USA |
VTRS Viatris Inc. | 863.42 k | 71.48 k shares | 0.92 | Common equity | Long | USA |
Royalty Pharma plc, Class A
|
786.07 k | 27.08 k shares | 0.83 | Common equity | Long | UK |
SRPT Sarepta Therapeutics, Inc. | 769.60 k | 5.67 k shares | 0.82 | Common equity | Long | USA |
NBIX Neurocrine Biosciences, Inc. | 767.57 k | 6.04 k shares | 0.81 | Common equity | Long | USA |
Total Return Swap
Societe Generale
|
748.81 k | 1.35 k contracts | 0.79 | Equity derivative | N/A | USA |
INSM Insmed Incorporated | 740.08 k | 9.68 k shares | 0.78 | Common equity | Long | USA |
MEDP Medpace Holdings, Inc. | 660.80 k | 1.86 k shares | 0.70 | Common equity | Long | USA |
SMMT Summit Therapeutics Inc. | 546.96 k | 42.14 k shares | 0.58 | Common equity | Long | USA |
Roivant Sciences Ltd.
|
542.34 k | 44.35 k shares | 0.58 | Common equity | Long | Bermuda |
PCVX Vaxcyte, Inc. | 527.44 k | 6.53 k shares | 0.56 | Common equity | Long | USA |
BNTX BioNTech SE | 519.26 k | 5.89 k shares | 0.55 | Common equity | Long | Germany |
Total Return Swap
Goldman Sachs International
|
513.60 k | 1.32 k contracts | 0.54 | Equity derivative | N/A | USA |
BeiGene Ltd.
|
492.30 k | 2.57 k shares | 0.52 | Common equity | Long | Cayman Islands |
HALO Halozyme Therapeutics, Inc. | 488.13 k | 7.65 k shares | 0.52 | Common equity | Long | USA |
ASND Ascendis Pharma A/S | 481.39 k | 3.48 k shares | 0.51 | Common equity | Long | Denmark |
ITCI Intra-Cellular Therapies, Inc. | 464.45 k | 6.34 k shares | 0.49 | Common equity | Long | USA |
EXEL Exelixis, Inc. | 455.19 k | 17.49 k shares | 0.48 | Common equity | Long | USA |
Jazz Pharmaceuticals plc
|
438.98 k | 3.79 k shares | 0.47 | Common equity | Long | Ireland |
Total Return Swap
Bank of America NA
|
435.09 k | 6.52 k contracts | 0.46 | Equity derivative | N/A | USA |
RVMD Revolution Medicines, Inc. | 422.21 k | 9.90 k shares | 0.45 | Common equity | Long | USA |
IONS Ionis Pharmaceuticals, Inc. | 417.72 k | 8.76 k shares | 0.44 | Common equity | Long | USA |
CYTK Cytokinetics, Incorporated | 392.88 k | 6.88 k shares | 0.42 | Common equity | Long | USA |
BPMC Blueprint Medicines Corporation | 359.13 k | 3.76 k shares | 0.38 | Common equity | Long | USA |
KRYS Krystal Biotech, Inc. | 334.44 k | 1.71 k shares | 0.35 | Common equity | Long | USA |
Repurchase Agreement | 320.74 k | 320.74 k principal | 0.34 | Repurchase agreement | Long | USA |
MDGL Madrigal Pharmaceuticals, Inc. | 316.33 k | 1.28 k shares | 0.34 | Common equity | Long | USA |
BBIO BridgeBio Pharma, Inc. | 312.84 k | 11.23 k shares | 0.33 | Common equity | Long | USA |
NUVL Nuvalent, Inc. | 302.13 k | 3.55 k shares | 0.32 | Common equity | Long | USA |
Alkermes plc
|
289.00 k | 10.16 k shares | 0.31 | Common equity | Long | Ireland |
APLS Apellis Pharmaceuticals, Inc. | 283.43 k | 7.29 k shares | 0.30 | Common equity | Long | USA |
RARE Ultragenyx Pharmaceutical Inc. | 283.39 k | 4.99 k shares | 0.30 | Common equity | Long | USA |
LEGN Legend Biotech Corporation | 282.23 k | 4.90 k shares | 0.30 | Common equity | Long | Cayman Islands |
DYN Dyne Therapeutics, Inc. | 271.24 k | 5.89 k shares | 0.29 | Common equity | Long | USA |
IMVT Immunovant, Inc. | 270.90 k | 8.77 k shares | 0.29 | Common equity | Long | USA |
Total Return Swap
Citibank NA
|
254.15 k | 886.00 contracts | 0.27 | Equity derivative | N/A | USA |
AXSM Axsome Therapeutics, Inc. | 253.34 k | 2.85 k shares | 0.27 | Common equity | Long | USA |
RNA Avidity Biosciences, Inc. | 252.60 k | 5.74 k shares | 0.27 | Common equity | Long | USA |
CRNX Crinetics Pharmaceuticals, Inc. | 251.19 k | 4.73 k shares | 0.27 | Common equity | Long | USA |
CRISPR Therapeutics AG
|
243.28 k | 5.10 k shares | 0.26 | Common equity | Long | Switzerland |
ADMA ADMA Biologics, Inc. | 240.87 k | 13.92 k shares | 0.26 | Common equity | Long | USA |
Repurchase Agreement | 240.56 k | 240.56 k principal | 0.26 | Repurchase agreement | Long | USA |
Total Return Swap
Morgan Stanley & Co. International plc
|
224.10 k | 683.00 contracts | 0.24 | Equity derivative | N/A | USA |
ACLX Arcellx, Inc. | 220.72 k | 3.21 k shares | 0.23 | Common equity | Long | USA |
DNLI Denali Therapeutics Inc. | 209.23 k | 8.56 k shares | 0.22 | Common equity | Long | USA |
FOLD Amicus Therapeutics, Inc. | 206.44 k | 17.78 k shares | 0.22 | Common equity | Long | USA |
Merus NV
|
202.74 k | 3.98 k shares | 0.22 | Common equity | Long | Netherlands |
IOVA Iovance Biotherapeutics, Inc. | 195.88 k | 16.80 k shares | 0.21 | Common equity | Long | USA |
GH Guardant Health, Inc. | 187.89 k | 7.35 k shares | 0.20 | Common equity | Long | USA |
SWTX SpringWorks Therapeutics, Inc. | 185.48 k | 4.45 k shares | 0.20 | Common equity | Long | USA |
XENE Xenon Pharmaceuticals Inc. | 182.78 k | 4.53 k shares | 0.19 | Common equity | Long | Canada |
IDYA IDEAYA Biosciences, Inc. | 179.45 k | 4.54 k shares | 0.19 | Common equity | Long | USA |
KYMR Kymera Therapeutics, Inc. | 178.11 k | 3.68 k shares | 0.19 | Common equity | Long | USA |
ARWR Arrowhead Pharmaceuticals, Inc. | 177.68 k | 7.46 k shares | 0.19 | Common equity | Long | USA |
RYTM Rhythm Pharmaceuticals, Inc. | 173.08 k | 3.66 k shares | 0.18 | Common equity | Long | USA |
GERN Geron Corporation | 169.12 k | 35.61 k shares | 0.18 | Common equity | Long | USA |
ACAD ACADIA Pharmaceuticals Inc. | 164.42 k | 9.92 k shares | 0.17 | Common equity | Long | USA |
IBRX ImmunityBio, Inc. | 163.98 k | 41.52 k shares | 0.17 | Common equity | Long | USA |
PTCT PTC Therapeutics, Inc. | 162.61 k | 4.60 k shares | 0.17 | Common equity | Long | USA |
Repurchase Agreement | 160.37 k | 160.37 k principal | 0.17 | Repurchase agreement | Long | USA |
AGIO Agios Pharmaceuticals, Inc. | 156.46 k | 3.41 k shares | 0.17 | Common equity | Long | USA |
MYGN Myriad Genetics, Inc. | 153.83 k | 5.43 k shares | 0.16 | Common equity | Long | USA |
TWST Twist Bioscience Corporation | 151.12 k | 3.50 k shares | 0.16 | Common equity | Long | USA |
PTGX Protagonist Therapeutics, Inc. | 151.02 k | 3.52 k shares | 0.16 | Common equity | Long | USA |
VCEL Vericel Corporation | 150.71 k | 2.92 k shares | 0.16 | Common equity | Long | USA |
JANX Janux Therapeutics, Inc. | 146.25 k | 3.11 k shares | 0.16 | Common equity | Long | USA |
VCYT Veracyte, Inc. | 144.85 k | 4.59 k shares | 0.15 | Common equity | Long | USA |
AMPH Amphastar Pharmaceuticals, Inc. | 143.10 k | 2.94 k shares | 0.15 | Common equity | Long | USA |
APGE Apogee Therapeutics, Inc. | 138.01 k | 2.70 k shares | 0.15 | Common equity | Long | USA |
BEAM Beam Therapeutics Inc. | 131.80 k | 4.94 k shares | 0.14 | Common equity | Long | USA |
NTLA Intellia Therapeutics, Inc. | 129.97 k | 5.79 k shares | 0.14 | Common equity | Long | USA |
Novocure Ltd.
|
125.56 k | 6.46 k shares | 0.13 | Common equity | Long | Jersey |
VERA Vera Therapeutics, Inc. | 124.16 k | 3.28 k shares | 0.13 | Common equity | Long | USA |
FTRE Fortrea Holdings Inc. | 123.74 k | 5.37 k shares | 0.13 | Common equity | Long | USA |
HRMY Harmony Biosciences Holdings, Inc. | 122.66 k | 3.41 k shares | 0.13 | Common equity | Long | USA |
MIRM Mirum Pharmaceuticals, Inc. | 122.00 k | 2.83 k shares | 0.13 | Common equity | Long | USA |
SUPN Supernus Pharmaceuticals, Inc. | 116.03 k | 3.30 k shares | 0.12 | Common equity | Long | USA |
Verona Pharma plc
|
114.98 k | 4.18 k shares | 0.12 | Common equity | Long | UK |
LGND Ligand Pharmaceuticals Incorporated | 114.16 k | 1.08 k shares | 0.12 | Common equity | Long | USA |
AKRO Akero Therapeutics, Inc. | 112.91 k | 4.15 k shares | 0.12 | Common equity | Long | USA |
GPCR Structure Therapeutics Inc. | 112.10 k | 2.94 k shares | 0.12 | Common equity | Long | Cayman Islands |
BCRX BioCryst Pharmaceuticals, Inc. | 107.65 k | 12.39 k shares | 0.11 | Common equity | Long | USA |
ARVN Arvinas, Inc. | 107.47 k | 4.11 k shares | 0.11 | Common equity | Long | USA |
EWTX Edgewise Therapeutics, Inc. | 105.13 k | 5.61 k shares | 0.11 | Common equity | Long | USA |
SNDX Syndax Pharmaceuticals, Inc. | 104.85 k | 5.10 k shares | 0.11 | Common equity | Long | USA |
NVAX Novavax, Inc. | 104.35 k | 8.43 k shares | 0.11 | Common equity | Long | USA |
RCKT Rocket Pharmaceuticals, Inc. | 102.79 k | 5.45 k shares | 0.11 | Common equity | Long | USA |
MNKD MannKind Corporation | 102.33 k | 16.35 k shares | 0.11 | Common equity | Long | USA |
RXRX Recursion Pharmaceuticals, Inc. | 100.63 k | 13.82 k shares | 0.11 | Common equity | Long | USA |
KROS Keros Therapeutics, Inc. | 98.23 k | 2.17 k shares | 0.10 | Common equity | Long | USA |
KURA Kura Oncology, Inc. | 96.31 k | 4.57 k shares | 0.10 | Common equity | Long | USA |
NRIX Nurix Therapeutics, Inc. | 89.71 k | 3.56 k shares | 0.10 | Common equity | Long | USA |
DVAX Dynavax Technologies Corporation | 88.16 k | 7.86 k shares | 0.09 | Common equity | Long | USA |
Avadel Pharmaceuticals plc
|
87.53 k | 5.77 k shares | 0.09 | Common equity | Long | Ireland |
ARDX Ardelyx, Inc. | 86.80 k | 14.05 k shares | 0.09 | Common equity | Long | USA |
HROW Harrow Health, Inc. | 85.94 k | 2.12 k shares | 0.09 | Common equity | Long | USA |
OCUL Ocular Therapeutix, Inc. | 82.01 k | 9.30 k shares | 0.09 | Common equity | Long | USA |
SANA Sana Biotechnology, Inc. | 80.45 k | 13.30 k shares | 0.09 | Common equity | Long | USA |
IMCR Immunocore Holdings plc | 80.30 k | 2.24 k shares | 0.09 | Common equity | Long | UK |
ANIP ANI Pharmaceuticals, Inc. | 80.20 k | 1.26 k shares | 0.09 | Common equity | Long | USA |
TNGX Tango Therapeutics, Inc. | 75.87 k | 6.41 k shares | 0.08 | Common equity | Long | USA |
ARQT Arcutis Biotherapeutics, Inc. | 75.61 k | 6.95 k shares | 0.08 | Common equity | Long | USA |
COLL Collegium Pharmaceutical, Inc. | 75.54 k | 1.96 k shares | 0.08 | Common equity | Long | USA |
SPRY ARS Pharmaceuticals, Inc. | 75.50 k | 5.82 k shares | 0.08 | Common equity | Long | USA |
IRON Disc Medicine, Inc. | 75.37 k | 1.48 k shares | 0.08 | Common equity | Long | USA |
INVA Innoviva, Inc. | 72.66 k | 3.75 k shares | 0.08 | Common equity | Long | USA |
DAWN Day One Biopharmaceuticals, Inc. | 72.60 k | 5.25 k shares | 0.08 | Common equity | Long | USA |
MRVI Maravai LifeSciences Holdings, Inc. | 72.15 k | 7.97 k shares | 0.08 | Common equity | Long | USA |
Prothena Corp. plc
|
72.00 k | 3.23 k shares | 0.08 | Common equity | Long | Ireland |
Genmab A/S
|
69.94 k | 2.52 k shares | 0.07 | Common equity | Long | Denmark |
Grifols SA
|
68.41 k | 7.32 k shares | 0.07 | Common equity | Long | Spain |
CGEM Cullinan Oncology, Inc. | 67.82 k | 3.46 k shares | 0.07 | Common equity | Long | USA |
VIR Vir Biotechnology, Inc. | 67.46 k | 8.17 k shares | 0.07 | Common equity | Long | USA |
XNCR Xencor, Inc. | 64.75 k | 3.70 k shares | 0.07 | Common equity | Long | USA |
Kiniksa Pharmaceuticals International plc, Class A
|
64.68 k | 2.42 k shares | 0.07 | Common equity | Long | UK |
ANAB AnaptysBio, Inc. | 62.47 k | 1.64 k shares | 0.07 | Common equity | Long | USA |
ELVN Enliven Therapeutics, Inc. | 61.79 k | 2.82 k shares | 0.07 | Common equity | Long | USA |
COGT Cogent Biosciences, Inc. | 61.64 k | 5.74 k shares | 0.07 | Common equity | Long | USA |
Zai Lab Ltd.
|
61.61 k | 3.09 k shares | 0.07 | Common equity | Long | Cayman Islands |
TARS Tarsus Pharmaceuticals, Inc. | 61.49 k | 2.27 k shares | 0.07 | Common equity | Long | USA |
EOLS Evolus, Inc. | 59.71 k | 3.76 k shares | 0.06 | Common equity | Long | USA |
AUPH Aurinia Pharmaceuticals Inc. | 58.46 k | 8.59 k shares | 0.06 | Common equity | Long | Canada |
PHAT Phathom Pharmaceuticals, Inc. | 58.03 k | 3.51 k shares | 0.06 | Common equity | Long | USA |
ETNB 89bio, Inc. | 56.11 k | 5.91 k shares | 0.06 | Common equity | Long | USA |
PETQ PetIQ, Inc. | 54.17 k | 1.77 k shares | 0.06 | Common equity | Long | USA |
RLAY Relay Therapeutics, Inc. | 54.10 k | 7.97 k shares | 0.06 | Common equity | Long | USA |
Zymeworks Inc. | 49.79 k | 4.25 k shares | 0.05 | Common equity | Long | USA |
CSTL Castle Biosciences, Inc. | 49.16 k | 1.66 k shares | 0.05 | Common equity | Long | USA |
IRWD Ironwood Pharmaceuticals, Inc. | 48.27 k | 9.54 k shares | 0.05 | Common equity | Long | USA |
PLRX Pliant Therapeutics, Inc. | 48.12 k | 3.62 k shares | 0.05 | Common equity | Long | USA |
AUTL Autolus Therapeutics plc | 47.06 k | 11.97 k shares | 0.05 | Common equity | Long | UK |
CNTA Centessa Pharmaceuticals plc | 46.97 k | 3.48 k shares | 0.05 | Common equity | Long | UK |
FDMT 4D Molecular Therapeutics, Inc. | 46.58 k | 3.10 k shares | 0.05 | Common equity | Long | USA |
BCYC Bicycle Therapeutics plc | 46.35 k | 2.16 k shares | 0.05 | Common equity | Long | UK |
ABCL AbCellera Biologics Inc. | 45.19 k | 17.65 k shares | 0.05 | Common equity | Long | Canada |
ERAS Erasca, Inc. | 45.08 k | 15.60 k shares | 0.05 | Common equity | Long | USA |
SRRK Scholar Rock Holding Corporation | 44.53 k | 4.79 k shares | 0.05 | Common equity | Long | USA |
ABUS Arbutus Biopharma Corporation | 43.84 k | 11.33 k shares | 0.05 | Common equity | Long | Canada |
PCRX Pacira BioSciences, Inc. | 43.47 k | 2.79 k shares | 0.05 | Common equity | Long | USA |
TVTX Travere Therapeutics, Inc. | 43.28 k | 4.57 k shares | 0.05 | Common equity | Long | USA |
HUMA Humacyte, Inc. | 43.25 k | 7.15 k shares | 0.05 | Common equity | Long | USA |
CureVac NV
|
42.28 k | 13.47 k shares | 0.04 | Common equity | Long | Netherlands |
WaVe Life Sciences Ltd.
|
42.19 k | 7.35 k shares | 0.04 | Common equity | Long | Singapore |
ORIC ORIC Pharmaceuticals, Inc. | 41.97 k | 4.05 k shares | 0.04 | Common equity | Long | USA |
ADPT Adaptive Biotechnologies Corporation | 41.57 k | 8.85 k shares | 0.04 | Common equity | Long | USA |
RVNC Revance Therapeutics, Inc. | 41.12 k | 6.26 k shares | 0.04 | Common equity | Long | USA |
OLMA Olema Pharmaceuticals, Inc. | 39.60 k | 3.36 k shares | 0.04 | Common equity | Long | USA |
SIGA SIGA Technologies, Inc. | 38.54 k | 4.27 k shares | 0.04 | Common equity | Long | USA |
YMAB Y-mAbs Therapeutics, Inc. | 37.69 k | 2.63 k shares | 0.04 | Common equity | Long | USA |
ITOS iTeos Therapeutics, Inc. | 37.68 k | 2.24 k shares | 0.04 | Common equity | Long | USA |
LXRX Lexicon Pharmaceuticals, Inc. | 37.54 k | 21.70 k shares | 0.04 | Common equity | Long | USA |
REPL Replimune Group, Inc. | 37.49 k | 3.69 k shares | 0.04 | Common equity | Long | USA |
MLYS Mineralys Therapeutics, Inc. | 36.98 k | 2.98 k shares | 0.04 | Common equity | Long | USA |
RGNX REGENXBIO Inc. | 36.12 k | 2.96 k shares | 0.04 | Common equity | Long | USA |
GLPG Galapagos NV | 35.53 k | 1.22 k shares | 0.04 | Common equity | Long | Belgium |
SVRA Savara Inc. | 35.42 k | 8.30 k shares | 0.04 | Common equity | Long | USA |
Arcturus Therapeutics Holdings, Inc. | 34.12 k | 1.62 k shares | 0.04 | Common equity | Long | USA |
KALV KalVista Pharmaceuticals, Inc. | 33.90 k | 2.53 k shares | 0.04 | Common equity | Long | USA |
VERV Verve Therapeutics, Inc. | 33.76 k | 5.04 k shares | 0.04 | Common equity | Long | USA |
ALLO Allogene Therapeutics, Inc. | 32.96 k | 12.53 k shares | 0.03 | Common equity | Long | USA |
HCM HUTCHMED (China) Limited | 32.49 k | 1.86 k shares | 0.03 | Common equity | Long | Cayman Islands |
FULC Fulcrum Therapeutics, Inc. | 31.88 k | 3.73 k shares | 0.03 | Common equity | Long | USA |
PRME Prime Medicine, Inc. | 30.84 k | 7.21 k shares | 0.03 | Common equity | Long | USA |
AVXL Anavex Life Sciences Corp. | 30.58 k | 5.08 k shares | 0.03 | Common equity | Long | USA |
ALEC Alector, Inc. | 30.54 k | 5.79 k shares | 0.03 | Common equity | Long | USA |
SAGE Sage Therapeutics, Inc. | 30.45 k | 3.61 k shares | 0.03 | Common equity | Long | USA |
UroGen Pharma Ltd.
|
30.18 k | 2.17 k shares | 0.03 | Common equity | Long | Israel |
OABI OmniAb, Inc. | 29.58 k | 7.06 k shares | 0.03 | Common equity | Long | USA |
TERN Terns Pharmaceuticals, Inc. | 29.57 k | 3.88 k shares | 0.03 | Common equity | Long | USA |
SLRN Acelyrin, Inc. | 28.41 k | 5.94 k shares | 0.03 | Common equity | Long | USA |
THRD Third Harmonic Bio, Inc. | 28.39 k | 2.46 k shares | 0.03 | Common equity | Long | USA |
EYPT EyePoint Pharmaceuticals, Inc. | 28.00 k | 3.13 k shares | 0.03 | Common equity | Long | USA |
MXCT MaxCyte, Inc. | 27.11 k | 6.28 k shares | 0.03 | Common equity | Long | USA |
TRML Tourmaline Bio, Inc. | 25.93 k | 1.54 k shares | 0.03 | Common equity | Long | USA |
PAHC Phibro Animal Health Corporation | 25.62 k | 1.22 k shares | 0.03 | Common equity | Long | USA |
TSHA Taysha Gene Therapies, Inc. | 25.15 k | 11.23 k shares | 0.03 | Common equity | Long | USA |
Xeris Pharmaceuticals Inc | 25.01 k | 8.90 k shares | 0.03 | Common equity | Long | USA |
Theravance Biopharma, Inc.
|
24.08 k | 2.92 k shares | 0.03 | Common equity | Long | Cayman Islands |